What is NeuraLight?
Founded in 2021 and headquartered in Austin, Texas, NeuraLight is dedicated to improving the lives of individuals suffering from neurological conditions. The company's core mission involves digitizing the complex processes of neurological analysis and treatment, making advanced care more accessible and effective. By leveraging technology, NeuraLight aims to provide a comprehensive digital platform that supports both diagnosis and ongoing management of neurological disorders, marking a significant advancement in the digital health sector.
How much funding has NeuraLight raised?
NeuraLight has raised a total of $30.5M across 2 funding rounds:
Angel/Seed
$5.5M
Series A
$25M
Angel/Seed (2021): $5.5M with participation from Kli, MSAD, Operator Partners, VSC Ventures, and Tuesday
Series A (2022): $25M led by Koch Disruptive Technologies, VSC Ventures, Lily Sarafan, Chris Mansi, Samsung NEXT, Breyer Capital, and David Golan
Key Investors in NeuraLight
Samsung NEXT
Samsung NEXT, founded in 2012 and headquartered in Mountain View, California, provides software and services to complement Samsung's global hardware footprint. Samsung NEXT combines product development, investment, M&A and partnerships under one roof.
Breyer Capital
Breyer Capital is an independent global venture capital and private equity investor founded by Jim Breyer in 2006, focusing on long-term, idea-driven investments. The firm aims to catalyze high-impact entrepreneurs by leveraging insights from a network of world-class investors and a belief in the transformative power of artificial intelligence and machine learning. Breyer Capital has a diverse portfolio that includes notable companies such as Meta, Spotify, and Epic Games. Their target clients are innovative entrepreneurs and technology-driven companies across various sectors including AI, consumer software, and fintech.
Koch Disruptive Technologies
Koch Disruptive Technologies is an investment firm focused on backing transformative technologies and innovative companies that have the potential to reshape industries. Their investment thesis often centers on disruptive innovations and advanced materials.
What's next for NeuraLight?
The recent major strategic investment signifies a critical juncture for NeuraLight, likely enabling the company to scale its operations, expand its research and development initiatives, and broaden its market reach. This capital infusion is expected to fuel the further refinement of its digital neurological analysis tools and treatment platforms. As NeuraLight continues to innovate in the health tech space, its focus will likely remain on enhancing patient outcomes and establishing a strong presence in the competitive landscape of neurological care solutions.
See full NeuraLight company page
